Why Doctors Can't Actually Prescribe Your Innovation: The 68% Roadblock

Why Doctors Can't Actually Prescribe Your Innovation: The 68% Roadblock
By: Women's HealthX Editorial

The bottleneck in women's health is no longer clinical willingness - it is administrative gatekeeping.

Boston MA -- October 27: New therapeutics and maternal-fetal diagnostics are being developed faster than payer utilization management protocols can adapt.

The Women's Health Infrastructure Report 2026 exposes a critical cross-sector disconnect between frontline clinical readiness and archaic insurance infrastructure.

The Friction
Over 68% of clinicians identify insurance reimbursement restrictions and prior authorization delays as their primary barrier to adopting sex-specific innovations, while only 5% cite hospital EHR integration.
The Reality
Providers are being turned into administrative negotiators rather than care deliverers. Health-tech integration is ready, but utilization management protocols are paralyzing adoption.
The Fix?
Scaling women's health requires biopharma and digital health platforms to integrate automated prior-authorization and real-time coverage verification directly into clinical workflows, treating reimbursement navigation as a primary product feature rather than an afterthought.
Sarah Cigna
"Prior authorizations are one of the most disruptive processes introduced by insurance companies in my day to day practice... Results in delays in patients being able to get imaging studies... which borders on practicing medicine without a license."
Sarah Cigna
Director, Sexual Health and Gender Affirmation (SAGA) Center, GW Medical Faculty Associates

This structural disconnect represents just one of the critical commercial gaps uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.

The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.

Lead Research Partner
Foraviset

Women’s HealthX 2026 | From Rhetoric to Results

Encore Boston Harbor | December 3-4 2026

Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.